Recognizing pharmaceutical philanthropy's role in fighting NTDs
"In October 1987, Roy Vagelos, then the chief executive of pharmaceutical company Merck, launched the largest pharmaco-philanthropic venture ever," William Foege, an epidemiologist and former director...
View ArticleGuardian examines challenges of eliminating river blindness in Africa
The Guardian's "Global Development Professionals Network" blog "reports on the challenges of eliminating river blindness from Africa by 2025."
View ArticleNEJM examines global disease eradication efforts
"Since the last case of naturally occurring smallpox, in 1977, there have been three major international conferences devoted to the concept of disease eradication," an article in the New England...
View ArticleWHO reports unprecedented progress against 17 neglected tropical diseases
WHO reports unprecedented progress against 17 neglected tropical diseases, thanks to a new global strategy, a regular supply of quality assured, cost-effective medicines and support from global partners.
View ArticleHead-scratching persists despite nodding syndrome study
Nodding syndrome is an epileptic disorder, with telltale nodding episodes caused by atonic seizures, concludes a pioneering study of the mysterious neurologic illness that has been reported in only...
View ArticleDisease eradication efforts set sights on polio, Guinea worm
"It's not a race, exactly, but there's an intriguing uncertainty about whether a former U.S. president or a software magnate will cause the next deliberate extinction of a species in the wild. Will...
View ArticleNew Pope will need to consider burden of NTDs
"Almost certainly, in its deliberations [to select a new Pope,] the conclave of cardinals will consider a number of difficult and well-publicized problems now facing the Catholic Church," Peter Hotez,...
View ArticleTSRI receives fund to develop new field test for Onchocerciasis
Philanthropist, businessman and community leader John Moores has given The Scripps Research Institute approximately $2 million to fund the development of a new field test for Onchocerciasis, or river...
View ArticleAnacor signs research agreement to discover drug candidates to treat...
Anacor Pharmaceuticals today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two...
View ArticleLindsley F. Kimball Research Institute receives grant for global health and...
The Lindsley F. Kimball Research Institute of the New York Blood Center announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.
View ArticleLiverpool School of Tropical Medicine receives US$ 10 million to continue...
Liverpool School of Tropical Medicine (LSTM) has received US$ 10 million from the Bill & Melinda Gates Foundation to continue their breakthrough drug discovery and development research against...
View ArticleHuman filariasis research: an interview with Professor Mark Taylor, Liverpool...
Filariasis refers to a group of diseases caused by parasitic worms, which are transmitted by blood feeding insects. Two species infect the lymphatic and blood systems causing lymphatic filariasis,...
View ArticleDFID awards 5-year grant to DNDi to advance research and development for...
The UK Department for International Development (DFID) has announced its renewed support to the Drugs for Neglected Diseases initiative (DNDi), allocating a total of - 30 million (- 35 million) over...
View ArticleLSTM professor awarded The Manson Medal for outstanding contribution in field...
The Liverpool School of Tropical Medicine (LSTM) is delighted that Emeritus Professor and Senior Professional Fellow, David Molyneux, has been awarded The Manson Medal, the Royal Society of Tropical...
View ArticleStudy finds persistent deficiency in new therapeutics for neglected diseases
In a study published today in the open-access journal The Lancet Global Health, the Drugs for Neglected Diseases initiative and other researchers report a persistent deficiency in truly new...
View ArticleLSTM and University of Liverpool receive GHIT Fund to target lymphatic...
The Liverpool School of Tropical Medicine (LSTM) together with colleagues at the Department of Chemistry (University of Liverpool (UoL)) and Japanese pharmaceutical company Eisai are pleased to...
View ArticleGHIT Fund announces grants to speed up innovative drug development for...
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced three...
View ArticleResearchers developing new medication to tackle river blindness and...
Researchers are developing new drug treatments to tackle river blindness and elephantiasis, which affect up to 150 million people across the world.
View ArticleCelgene Global Health, DNDi expand partnership to identify new drug...
Celgene Global Health, a division of Celgene Corporation, and the Drugs for Neglected Diseases initiative strengthen their collaboration with a four-year Research Collaboration Agreement to identify...
View ArticleBlackflies infected with Onchocerca volvulus parasite may spread nodding...
Despite decades of research, scientists have yet to pinpoint the exact cause of nodding syndrome (NS), a disabling disease affecting African children. A new report suggests that blackflies infected...
View Article